Edition:
India

McKesson Corp (MCK.N)

MCK.N on New York Stock Exchange

153.96USD
26 Apr 2018
Change (% chg)

$2.25 (+1.48%)
Prev Close
$151.71
Open
$152.73
Day's High
$154.13
Day's Low
$150.60
Volume
388,564
Avg. Vol
432,879
52-wk High
$178.86
52-wk Low
$134.28

Chart for

About

McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, government... (more)

Overall

Beta: 1.24
Market Cap(Mil.): $31,810.32
Shares Outstanding(Mil.): 210.26
Dividend: 0.34
Yield (%): 0.90

Financials

  MCK.N Industry Sector
P/E (TTM): 6.74 20.98 40.93
EPS (TTM): 22.46 -- --
ROI: 22.49 11.72 62.12
ROE: 47.16 13.91 73.69

BRIEF-McKesson Launches Multi-Year Strategic Growth Initiative; Reaffirms Fiscal 2018 Outlook

* MCKESSON LAUNCHES MULTI-YEAR STRATEGIC GROWTH INITIATIVE; REAFFIRMS FISCAL 2018 OUTLOOK AND PROVIDES PRELIMINARY FISCAL 2019 OUTLOOK

26 Apr 2018

BRIEF-Polarityte Announces Appointment Of Mckesson’S Willie Bogan To Board Of Directors

* POLARITYTE ANNOUNCES APPOINTMENT OF MCKESSON’S WILLIE BOGAN TO BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

24 Apr 2018

Glenview's Robbins says talk of Amazon's entering pharma is overblown

NEW YORK Glenview Capital Management Chief Executive Larry Robbins said on Monday at the Sohn Investment Conference in New York that he still likes a trio of stocks he already owns, citing CVS Health Corp , McKesson Corp and Express Scripts Holdings .

24 Apr 2018

UPDATE 1-Glenview's Robbins says talk of Amazon's entering pharma is overblown

NEW YORK, April 23 Glenview Capital Management Chief Executive Larry Robbins said on Monday at the Sohn Investment Conference in New York that he still likes a trio of stocks he already owns, citing CVS Health Corp, McKesson Corp and Express Scripts Holdings.

24 Apr 2018

BRIEF-McKesson Corp Files Preliminary Prospectus Supplement Related To A Potential Two-Part Note Offering

* MCKESSON CORP FILES PRELIMINARY PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL TWO-PART NOTE OFFERING OF UP TO EUR 750 MILLION - SEC FILING Source text : (http://bit.ly/2H0ogwC) Further company coverage:

09 Feb 2018

BRIEF-McKesson Corp Files Preliminary Prospectus Supplement Related To A Potential Notes Due 2028

* MCKESSON CORP FILES PRELIMINARY PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL NOTES DUE 2028 OFFERING OF UP TO $600 MILLION - SEC FILING Source text : (http://bit.ly/2G22iIb) Further company coverage:

09 Feb 2018

BRIEF-Mckesson Files Preliminary Prospectus Supplement Related To Potential Offering Of Notes

* MCKESSON CORP FILES PRELIMINARY PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL OFFERING OF NOTES DUE 2020 - SEC FILING Source text - http://bit.ly/2FUEDJW Further company coverage:

07 Feb 2018

UPDATE 3-McKesson says drug prices competitive but not volatile like 2017

* Books tax benefit of $370 mln in 3rd quarter (Adds company commentary on generic drug prices, background, analyst quotes; updates stock prices)

01 Feb 2018

CORRECTED-UPDATE 1-Drug distributor McKesson's quarterly profit beats estimates

Feb 1 McKesson Corp posted a better-than-expected quarterly profit, as the biggest U.S. drug distributor continues to benefit from its tie-up with Walmart .

01 Feb 2018

BRIEF-McKesson Reports Q3 Adjusted Earnings Per Share $3.41

* Q3 GAAP EARNINGS PER SHARE $4.32 FROM CONTINUING OPERATIONS

01 Feb 2018

Earnings vs. Estimates